IDEXX Laboratories
IDXX
$476.35
Share price
-0.30%
Change (1 day)
-1.20%
Change (1 year)
Categories
Operating Margin for IDEXX Laboratories (IDXX)
Operating Margin as of April 2024 (TTM): 25.53%
According to IDEXX Laboratories's latest financial reports and stock price the company's current Operating Margin is 25.53%. At the end of 2022 the company had an Operating Margin of 25.54%.
Operating Margin history for IDEXX Laboratories from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 25.54% | -9.03% |
| 2021 | 28.07% | 14.78% |
| 2020 | 24.46% | 12.73% |
| 2019 | 21.70% | 4.91% |
| 2018 | 20.68% | 6.87% |
| 2017 | 19.35% | 6.75% |
| 2016 | 18.13% | 6.31% |
| 2015 | 17.05% | 2.75% |
| 2014 | 16.59% | -13.2% |
| 2013 | 19.12% | -5.13% |
| 2012 | 20.15% | 4.76% |
| 2011 | 19.24% | 5% |
| 2010 | 18.32% | 8.28% |
| 2009 | 16.92% | 1.8% |
| 2008 | 16.62% | 13.7% |
| 2007 | 14.62% | -17.38% |
| 2006 | 17.69% | -4.72% |
| 2005 | 18.57% | -8.23% |
| 2004 | 20.23% | 15.67% |
| 2003 | 17.49% | 4.96% |
| 2002 | 16.66% | 9.46% |
| 2001 | 15.23% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | 15.60% | -38.90% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 14.17% | -44.50% | 🇺🇸 USA |
 Henry Schein
HSIC | 4.89% | -80.85% | 🇺🇸 USA |
 Meridian Bioscience VIVO | 16.31% | -36.11% | 🇺🇸 USA |
 Neogen NEOG | -2.68% | -110.50% | 🇺🇸 USA |
 Heska Corporation
HSKA | -1.35% | -105.29% | 🇺🇸 USA |
 Petco WOOF | 3.18% | -87.54% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.